Publication Name	World Journal of Gastroenterology
Manuscript ID	5264
Country	Brazil

Received	2013-08-26 10:43
Peer-Review Started	2013-08-26 14:38
To Make the First Decision	2013-09-09 16:58
Return for Revision	2013-09-11 07:54
Revised	2013-09-28 06:22
Second Decision	2013-10-14 09:54
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-10-14 13:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-09 02:08
Typeset the Manuscript	2013-12-04 14:42
Publish the Manuscript Online	2013-12-18 10:00

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases
Manuscript Source	Invited Manuscript
All Author List	Adriana Haack, Giselle Gonçalves Aragão and Maria Rita Carvalho Garbi Novaes
Funding Agency and Grant Number
Corresponding Author	Adriana Haack, Professor of Nutrition, Department of Health, Universidade Paulista (UNIP), SHIGS 715 Block A House 87, Brasília Federal District, Brasília 70381701, Brazil. adrianahaack@hotmail.com
Key Words	Cystic fibrosis; Medication; Therapeutic; Absorption; Digestion
Core Tip	Cystic fibrosis (CF) has been studied in Brazil and in many other countries. Digestive manifestations may significantly compromise the nutritional status of CF patients, leading to numerous symptoms. Supplementation with enzymes, vitamins and nutrients is usually necessary. When infections are present, antibiotics are necessary, and these infections are often multisystemic, involving the digestive tract. The pharmaceutical assistance included in public policies, especially those which are financed, and the constant incentive to study the digestive manifestations in CF patients are essential, as without them, there would be infinite clinical changes which would compromise patient survival.
Publish Date	2013-12-18 10:00
Citation	Haack A, Aragão GG, Novaes MRCG. Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. World J Gastroenterol 2013; 19(46): 8552-8561
URL	http://www.wjgnet.com/1007-9327/full/v19/i46/8552.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i46.8552

Full Article (PDF)	WJG-19-8552.pdf
Manuscript File	5264-Review.doc
Answering Reviewers	5264-Answering reviewers.pdf
Copyright License Agreement	5264-Copyright assignment.pdf
Peer-review Report	5264-Peer review(s).pdf
Scientific Editor Work List	5264-Scientific editor work list.doc